Induction of apoptosis in imatinib sensitive and resistant chronic myeloid leukemia cells by efficient disruption of bcr-abl oncogene with zinc finger nucleases

BACKGROUND: The bcr-abl fusion gene is the pathological origin of chronic myeloid leukemia (CML) and plays a critical role in the resistance of imatinib. Thus, bcr-abl disruption-based novel therapeutic strategy may warrant exploration. In our study, we were surprised to find that the characteristic...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Exp Clin Cancer Res
Главные авторы: Huang, Ningshu, Huang, Zhenglan, Gao, Miao, Luo, Zhenhong, Zhou, Fangzhu, Liu, Lin, Xiao, Qing, Wang, Xin, Feng, Wenli
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5859405/
https://ncbi.nlm.nih.gov/pubmed/29554925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0732-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы